PositiveID (PSID) Partners with Leading Diabetes Research Organizations to Bring Products to Market
PositiveID Corp., a developer of medical technologies for diabetes management and molecular diagnostic systems, today announced its new partnership with the Diabetes Research Institute (DRI) at the University of Miami and Schneider Children's Medical Center of Israel (Schneider Children's). Through collaborative research, the partnership will support the continued development and study of PositiveID's diabetes management products. "We believe that joining forces with the DRI and Schneider Children's, two of the world's foremost diabetes research organizations, will enable us to accelerate the remaining development and study of our non-invasive diabetes management projects, and ultimately bring these ground-breaking products to market,” PositiveID…